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Abstract:    
This study was planned to investigate phytochemical constituents were isolated from the plant Albizia odoratissima 
and its antibiofilm activity were analysed. Three flavone compounds namely Eupatorin (1),6-methoxy flavone 
(2),6,2’,4’-trimethoxy flavone(3)  isolated from the stem bark and structure of the compounds  were established  
based on NMR prediction. Their were no biofilm results in all the three compounds.The antibiofilm activity was 
evaluated against three reference strains Pseudomonas aeruginosa,Klebseilla pneumonia, Staphylococcus 
epidermidis by microtitre plate method. Using above reference strains MIC and biofilm inhibition work were done 
by quantification and SEM. SEM images of the species biofilm inhibition confirmed compound 1,2 and 3 inhibits 
P.aeruginosa biofilm formation by 93.93%,95.04% and 94.72% at a concentration of 1ng/ml,1ng/ml and 1mg/ml. 
To compare the results compound 2 showed that  greater  biofilm inhibition activity against P.aeruginosa at very 
low concentration of (1ng/ml). The biofilm inhibition of P.aeruginosa of compound 2 on urinary catheter was 
evaluated using scanning electron microscopic analysis. 
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INTRODUCTION: 
A wide variety of microbial infections in the body 
(~80%) are caused by bacterial biofilm. A collection 
of microbial communities enclosed by a matrix of 
extracellular polymeric substance (EPS),which 
separated by a network of open water channels is 
called biofilm. Microbial communities adhere to 
manmade and natural surfaces, such as metals and 
surgicares, typically at liquid-solid interface  [1]. 
Major clinical importance because more than 60% of 
the bacterial infections currently treated by 
physicians in the developed world are considered due 
to biofilm formation (Fux et al. 2005) [2]. Biofilms 
have been recognized as being important inhuman 
disease, and the numbers of biofilm-associated 
infections are on the rise (Davies 2003) [3]. Different 
infections due to biofilm forming bacteria such as 
Escherichia coli, Staphylococcus aureus, Klebseilla 
pneumonia, Staphylococcus epidermidis in body 
tissues, leading to several diseases. In this work  three 
biofilm forming pathogen such as Pseudomonas 
aeruginosa, Klebsiella pneumonia and 
Staphylococcus epidermidis were used for biofilm 
inhibition studies. Pseudomonas aeruginosa is an 
opportunistic pathogen that forms biofilms on tissues 
and other surfaces and it is an important causative 
agent of a variety of acute and chronic infections, 
including burn, infections of respiratory tract, urinary 
tract, eye and ear [4]. Biofilm-associated diseases are 
common characteristic of  P. aeruginosa infections is 
that they are caused by bacterial association with 
surfaces, either human tissue or indwelling devices 
[5]. Severe underlying diseases caused by  
opportunistic pathogen such as Klebsiella pneumonia 
that infects immune compromised patients who are 
hospitalized or suffering from chronic pulmonary 
obstruction or diabetes(Allen et al., 1991). These 
bacterial infections can lead to complications, 
including urinary tract infections, septicemia and 
pneumonia in the elderly or in patients with 
predisposing factors (Williams and Tomas, 1990). 
Infections due to K. pneumoniae are particularly 
devastating with a mortality rate between 25 and 60% 
(Ellis, 1998). K. pneumoniae is naturally present at 
low concentrations in the environment, but also in the 
gastrointestinal tract and natural cavities of humans, 
and constitute aggregates called biofilms. 
Furthermore, formation of biofilms by K. 
pneumoniae on urinary catheters and intravenous and 
prosthetic heart valves has been documentted (Farber 
and Wolff, 1993; Galdiero et al., 1987; Liu, 1993). 
This property is considered as an important virulence 
factor for K. pneumoniae (Jagnow and Clegg, 2003) 
[6].  Staphylococcus epidermidis is one of the most 
commonly isolated bacterial pathogens in hospitals  
 
 
and the most frequent cause of nosocomial infections 
[7, 8, 9]. 
 
S.epidermidis is part of the normal human epithelial 
bacterial flora but can cause infections when the skin 
or mucous membrane is injured. S. epidermidis can 
develop into biofilms and become a persistent source 
of device-associated infections [10].  S.epidermidis 
plays a major role in biofilm-based medical-device-
related infections [11]. These bacterial communities 
pose a critical problem in everyday life, causing 
many economic and health problems. A biofilm on an 
indwelling urinary catheter consists of adherent 
microorganisms, their extracellular products, and host 
components deposited on the catheter. Catheter 
Associated Urinary Tract Infections (CAUTIs) are 
the most common form of hospital acquired 
infections - HAIs - with more than 560,000 
cases/year estimated in the US alone CAUTI is also 
the leading cause of secondary bloodstream 
infections. Therefore, alternative sources of 
antimicrobial substances are required. Currently 
natural products are a major source of chemical 
diversity and have provided important therapeutic 
agents for many bacterial diseases [12] and natural 
compounds  have no side effect and plant molecules 
are green and safe for prolonged use in the 
management of diseases. 
 
Plants offer a rich source of antimicrobial agents and 
other pharmaceuticals (Cowan 1999; Zhao et al. 
2005;Li & Vederas 2009). However, of the 500,000 
plant species, only 1% has been phytochemically 
investigated from the perspective of antimicrobial 
activity (Cowan 1999; Palombo 2009)[13]. As an 
adaptive evolution, many plant species produce 
metabolites that can control the growth of microbes 
and have traditionally been used to treat human 
diseases, particularly microbial infections[14].  
Polyphenols (especially flavonoids) from plants have 
been acting as potent antimicrobial molecules. 
Phenolic compounds have proven effective in 
inhibiting the growth and biofilm formation by 
pathogenic bacteria Flavonoids are a group of 
heterocyclic organic compounds that occur widely in 
the plant kingdom(Havsteen 1983). They are found in 
fruits, vegetables, nuts, seeds, stems, flowers as well 
as tea, wine (Middleton and Chithan 1993) and honey 
(Grange and Davey1990) and represent a common 
constituent of the human diet (Harborne and Baxter 
1999).Many flavonoids that are ubiquitous in the 
plant kingdom are biologically active in combating 
diseases due to their diverse beneficial roles in 
humans. 
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Herein, for the first time, we have isolated three 
flavone compounds namely Eupatorin [15-22],6-
methoxy flavone [23,  24],6,2’,4’-trimethoxy flavone  
from the stems and stem bark of Albizia odoratissima 
plant even though it was already isolated by the few 
groups from different plant sources. 
 
To our best of knowledge there are no reports 
available for antibiofilm activities of three flavone 
compounds.Therefore the present study was to 
investigate the isolation of three flavone compounds 
for the first time from the stem bark of Albizia 
odoratissima and  also report the antibiofilm effect of 
active three flavones against three biofilm forming 
bacteria such as Pseudomonas aeruginosa, Klebseilla 
pneumonia and Staphylococcus epidermidis by 
Microtitre plate method. 
 
MATERIALS AND METHODS: 
The NMR spectra for1H and 13C in CDCl3were 
recorded on a Bruker 300 spectrometer, with TMS. 
Electrospray ionization mass spectrometry (ESI-MS) 
analysis was performed in the positive ion mode on a 
liquid chromatography-ion trap mass spectrometer 
(LCQ Fleet, Thermo Fisher Instruments Limited, 
US).The samples were introduced into the ion source 
by in fusion method at flow rate 1µL/min. The 
capillary voltage of the mass spectrometer was 33 V, 
with source voltage 4.98 kV for the mass scale (m/z 
150–2000). 
 
Plant material 
The stem of Albizia odoratissima was collected from 
Madurai kamaraj university, Madurai at August 
2015. The stems were collected, washed with double 
distilled water and then dried at room temperature. 
 
Extraction and isolation of compounds 
Isolation of compound 1  
The stems were collected, washed with double 
distilled water and then dried at room temperature. 
The dried stems of the plant(2kg)were first extracted 
with petroleum ether(2L)using soxhlet apparatus for 
2 days. At first petroleum ether is used to remove 
wax from the plant material.Then extracted with 
chloroform (2L) for 2 days.The chloroform extract 
was evaporated to dryness under reduced pressure to 
yield a crude residue (10g).Its subsequent column 
chromatography on silica gel (60-120 mesh MERCK) 
eluted with Pet ether with increasing gradient of 
chloroform upto(100%) to gave 30 fractions that 
were monitored by TLC silicgel. The active fractions 
13-15 were repeatedly chromatographed on silicagel 
coumn and then, eluted with chloroform: methanol 
(90:10) as the developing solvent .Fraction-13, 14 
was obtained as a mixture of spot and fraction-15 
gave single spot on TLC and it was further purified 
and recrystallised from methanol to yield yellow 
colour compound 1 (10mg) and it was characterized 
by 1H NMR,13CNMR,ESI-MS and FT-IR techniques.  
 
Materials and methods 
The NMR spectra for1H and 13C in CDCl3were 
recorded on a Bruker 300 spectrometer, with TMS. 
Electrospray ionization mass spectrometry (ESI-MS) 
analysis was performed in the positive ion mode on a 
liquid chromatography-ion trap mass spectrometer 
(LCQ Fleet, Thermo Fisher Instruments Limited, 
US).The samples were introduced into the ion source 
by in fusion method at flow rate 1µL/min. The 
capillary voltage of the mass spectrometer was 33 V, 
with source voltage 4.98 kV for the mass scale (m/z 
150–2000). 
 
Plant material 
The stem of Albizia odoratissima was collected from 
Madurai kamaraj university, Madurai at August 
2015. The stems were collected, washed with double 
distilled water and then dried at room temperature. 
 
Extraction and isolation of compounds 
Isolation of compound 1  
The stems were collected, washed with double 
distilled water and then dried at room temperature. 
The dried stems of the plant (2kg) were first extracted 
with petroleum ether (2L)using soxhlet apparatus for 
2 days. At first petroleum ether is used to remove 
wax from the plant material.Then extracted with 
chloroform (2L) for 2 days.The chloroform extract 
was evaporated to dryness under reduced pressure to 
yield a crude residue (10g).Its subsequent column 
chromatography on silica gel (60-120 mesh MERCK) 
eluted with Pet ether with increasing gradient of 
chloroform upto (100%) to gave 30 fractions that 
were monitored by TLC silicgel. The active fractions 
13-15 were repeatedly chromatographed on silicagel 
coumn and then, eluted with chloroform: methanol 
(90:10)as the developing solvent .Fraction-13,14 was 
obtained as a mixture of spot and fraction-15 gave 
single spot on TLC and it was further purified and 
recrystallised from methanol to yield yellow colour 
compound 1 (10mg) and it was characterized by 1H 
NMR,13CNMR,ESI-MS and FT-IR techniques.  
 
Isolation of compound 2: 
The freshly collected,air dried and powdered stem 
bark(2kg) was exhaustively extracted with 
methanol(3x10 litres)for 3 days.The combined 
methanolic extract was evaporated under reduced 
pressure at room temperature to yield a crude 
residue(600g).The whole extract was suspended in 
water and successivey extracted with n-
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Hexane(100g),chloroform(50g),ethyl 
acetate(70g).The chloroform soluble fraction was 
subjected to column chromatography over silica gel  
and eluted with pet ether,pet ether-choroform, 
chloroform, chloroform-methanol with  gradient 
increase in polarity to yield 10 subfractions.The 8th  
subfractions were a binary mixture of two 
compounds that was rechromatographed over  
silicagel and eluted with pet ether-chloroform(8:2)to 
afford compound in pure form(20mg) and it was 
recrystallized from methanol to yield white colour 
needle shape compound obtained. 
 
Isolation of compound 3: 
The stem (2kg) were collected,dried at room 
temperature,grounded and then successively 
extracted with pet ether and chloroform. The 
chloroform extract was concentrated under reduced 
pressure to yield 100g of yellow viscous mass which 
was subjected to silic gel chromatography. The 
column was eluted with petether and then chloroform 
to give 5 fractions. Fraction 3 was separated by 
silicagel by eluting with CHCl3-acetone (4:1) to give 
4 subfractions. Subfraction 2 which was then purified 
on column eluting with CHCl3-MeOH (6:1) gave 4 
fractions. Fraction 3 contained a flavone which was 
further recrystallized from methanol, yielded 
compound 3 (10mg). 
 
Compounds identification: 
To determine the structure of  this compounds was 
established by comparison of its spectral data with 
previous literature values. 
 
Bacterial strains 
Pseudomonas aeruginosa, Klebsiella pneumonia, 
Staphylococcus epidermidis stains were isolated from 
different biological sources and were used for further 
biofilm inhibition assays. Bacterial samples were 
cultured on the following media: Luria bertani (LB) 
agar/broth medium (HiMedia Laboratories, India).  
 
Preparation of natural compounds 
The naturally isolated compounds 1,2 and 3 were 
dissolved in dimethyl sulphoxide at a concentration 
of 1mg/ml. 
 
Determination of minimum inhibitory 
concentration of natural compounds 
To determine the minimum inhibitory concentration 
(MIC) of the natural compounds 1,2 and 3 was 
evaluated against three bacterial pathogens by the 
broth microdilution method (Basri and Fan, 2005). 
The stock solutions of the natural compounds were 
dissolved in DMSO (Initial concentration, 1mg/mL). 
The initial test concentration was serially diluted 
(µg/ml,ng/ml). Each well was inoculated with 200µl 
of suspension containing 106CFU/ml1 of bacteria. 
The plates with bacteria were incubated at 370C for 
24 hours. The lowest concentration exhibiting 
complete inhibition of the microbial growth was 
taken as the MIC. The tubes were visually examined 
for the lowest concentration of isolated compound 
that showed inhibition of microbial growth (indicated 
by a clear solution) after 24 h .The experiment was 
performed in duplicate.  Bacterial suspensions were 
used as negative control, while broth containing 
standard drug(Ganamycin) was used as positive 
control. 
 
Biofilm inhibition assay 
Only those isolates were used in the biofilm-
inhibition assay. Test compounds were dissolved in 
DMSO (1mg/mL), and twofold dilutions were 
prepared to obtain a final concentration ranging from 
(mg/ml,µg/ml,ng/ml) in the wells after the addition of 
the freshly diluted LB broth culture containing 
106CFU/ml1 of biofilm-forming isolates per well as 
shown in Fig. 1  
 
 
 
Fig. 1:    a-Control (LB broth): b-Biofilm formation. 
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Fig. 2:  Biofilm inhibition assay 
 
After incubation at 370C for 24 hours, the planktonic 
suspension and nutrient solution were aspirated and 
each well was washed three times with 300 µL of 
sterile physiological saline. The plates were strongly 
shaken to remove all nonadherent bacteria. The 
remaining attached bacteria were fixed with 250 mL 
of 96% ethanol/well and, after 15minutes; the plates 
were emptied and left to dry. Each well was then 
stained for 5 minutes with 200µL of 2% crystal violet 
(CV Gramstain, Merck, Germany). The stain was 
rinsed off by placing the plates under running tap 
water. After drying the stained plates, biofilms were 
visible as purple rings on the sides of each well as 
shown in Fig. 2  
 
The quantitative analysis of biofilm formation was 
performed by adding 200 µL of 33 %( v/v) glacial 
acetic acid (Merck) perwell. The optical density (OD) 
of the stain was then measured at 595 nm using an 
enzyme-linked immunosorbent assay reader (Elisa, 
Germany) as described previously. The inhibitory 
effect of the compounds on biofilm production was 
calculated by subtracting the media control. The 
biofilm inhibitory concentration (BIC) is the 
concentration of the natural compound at which the 
biofilm formation was reduced to an absorbance 
(A595) < 0.5 OD. Each assay for BIC determination 
was performed in triplicate.The percentage of biofilm 
inhibition was calculated by the formula [25] 
 
Percentage of inhibition=([Control OD595 nm-Test 
OD570 nm]/Control OD595 nm)x100 
Scanning electron microscopy 
Scanning electron microscopy (SEM) was used to 
observe the architecture of P.aeuroginosa biofilms 
grown in the presence of compound 2 (0.5 × MIC 
concentration) and to evaluate the eradication of 
established biofilms treated with compound 2. 
Sample preparation of biofilms (24 h and preformed) 
were analyzed by Scanning Electron Microscopy 
(SEM) (VEGA-3, TESCON) follow-ing standard 
preparative techniques using CD1CN at 250mg/ml  
[26]. Briefly, biofilms were formed in 24-well 
microplates. Each sample was inoculated with a 
defined volume of overnight culture. Biofilms on the 
glass pieces were fixed for 2h in solution containing 
40%glutaraldehyde. Further the glass pieces were 
washed with phosphate buffer saline(pH-7) and dehy-
drated with alcohol (70% ethanol for 10 min, 95% 
ethanol for 10 min, and 100% ethanol for 20 min), 
and allowed to dry prior to gold sputtered. 
 
The scanning electron microscopy images of 
different biofilm producers shows effective inhibition 
against three compounds using P.aeruginosa. High 
(MBIC) minimum biofilm inhibitory concentration 
inferred at ng/ml of all the compounds.To compare 
the two concentrations, only nano concentrations of 
compound 2 shows very high inhibition assay. Based 
on these results the compound-2 was taken for further 
real sample testing.  
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Biofilm formation by P.aeruginosa on catheter 
Biofilms of P.aeruginosa were grown on small sterile 
catheter piece (surface area 1.0 cm2) cut from Foley 
catheter obtained from JIPMER, manufactured by 
SISCO latex Pvt.Ltd., (Pudhucherry). The material 
was sterilized with ethanol (70%) and rinsed with 
distilled water. Flat square pieces, 1.0 cm in 
diameter, were obtained by cutting with a sterile 
surgical knife, the protocol followed by Chandra et 
al.[27].  A 100µl quantity of the cell suspension was 
applied to the surfaces of 1.0 cm2 catheter piece 
placed in a sterile petri plate. The cells were allowed 
to adhere for 90 min at 370C (adhesion phase). Non 
adherent cells were removed from the tube by gently 
washed with 5 ml of PBS. 
 
Coating catheters with natural compounds 
 Polyurethane triple-lumen central venous catheters 
(20 cm long and 13 gauge) that had been pretreated 
with the cationic surfactant 
tridodecylmethylammonium chloride to enable 
subsequent bonding of natural compounds. The 
compounds were prepared with three different 
concentrations using DMSO.  Bio-Guard catheters 
were dipped in ng/ml of all the compounds for 15 
min and were then removed and allowed to dry 
overnight. Then the processed and fresh catheters 
were used for biofilm inhibition assay against 
P.aeruginosa. 
 
Statistical analyses 
Biofilm inhibition data was statisticaly analysed by 
using Graph pad prism software [28]. All the 
experiments were performed in duplicates and data 
are expressed as mean ± standard deviation. The 
results were analysed using two-way ANOVA. where 
homogeneity of variances was not met,the non 
parametric Dunnett’s multiple comparison  test was 
applied. Results were presented as the mean standard 
deviation and differences were accepted as 
significant for p < 0.05(5% of the significance level). 
 
RESULTS AND DISCUSSION:    
Biofilm production assay by microtitre plate test 
The biofilm production assay shows higher 
production after 48h of incubation for three reference 
strains. Biofilm formation level was significantly 
more in P.aeruginosa when compare to K.pneumonia 
and S.epidermidis. K.pneumonia shows very low 
biofilm production while compare with other two 
strains. From this results biofilm inhibition assay was 
carried out using different natural compounds in 
different concentration levels as indicated in Fig. 3. 
 
 
 
Fig. 3:  Biofilm forming ability of  reference strains during 48h at 370C .The bars on the graph represent 
mean ± SD of biofilm formation from three independent experiments 
                                                                                                                                                                                                            
 
Determination of minimum inhibitory 
concentration of naturally isolated flavones 
The results of MIC values for compound 1,2 and 3 
tested against different biofilm producers as control 
are depicted in fig. 4,5 and 6. 
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Fig.4:  Minimum inhibitory concentration of compound 1, 2, and 3 in the presence of 
P.aeruginosa in a 96-well microtitre plate. Experiments were conducted in duplicate and error 
bars represent standard deviations 
 
Fig. 5:  Minimum inhibitory concentration of compound 1, 2, and 3 in the presence of K.pneumonia in a 96-
well microtitre plate. Experiments were conducted in duplicate and error bars represent standard deviations 
 
 
 
Fig. 6: Minimum inhibitory concentration of compound 1, 2, and 3 in the presence of  S.epidermidis  in a 96-
well microtitre plate. Experiments were conducted in duplicate and error bars represent standard deviations 
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The present experimental data demonstrated that a 
significant difference in the MIC of the natural 
compounds was noted as shown in Table 1. The MIC 
of compound 2 was 82.78 against K.pneumonia, 
whereas that of compound 3 and compound 1 was 
79.50 & 77.86, (MIC, compound 2 < 3 < 1). These 
results confirm that compound 2 and 3 is the most 
potent antimicrobial compound. 
 
Table 1: Percentage of Minimum Inhibitory Concentration (MIC) of compound 1,2 and 3 in biofilm 
producing isolates P.aeruginosa, K.pneumonia and S.epidermidis 
        Isolates           Compound 1   
 
 1mg          1µg         1ng 
            Compound  2  
 
1mg          1µg         1ng 
      Compound  3 
 
1mg          1µg         1ng 
P.aeruginosa 
 
K.pneumonia 
 
S.epidermidis 
 
 57.10        61.63       74.67  
 
77.86          69.97       63.72 
   
 39.68          32.01       30.55   
76.28         77.01       78.77  
 
79.61          80.94      82.78 
 
44.57           35.44     42.46 
76.86         76.72      76.72                  
 
71.72          75.71     79.50 
 
42.98           48.41    46.95 
 
Biofilm inhibition assay of compounds 
The minimum biofilm inhibitory concentration 
(MBIC) of compounds 1,2 & 3 was determined 
toward three strains from different sources, selected 
in the present study due to their strong biofilm-
forming ability. Two gram-negative and only one 
gram positive strain S.epidermidis used in this study. 
The compounds were used in three different 
concentrations (mg/ml,µg/ml,ng/ml) against three 
different cultures. As a result compound-1 shows 
93% of MBIC with 1ng/ml against K.pneumonia and 
S.epidermidis (fig. 7).Compound-2 shows maximum 
biofilm inhibition (95%) at 1ng/ml against strong 
biofilm producer P.aeruginosa. Results of the present 
study reveals that the compound 2 inhibited 
Pseudomonas aeuroginosa was at 95%(fig. 8) 
because one methoxy group present at meta position. 
In general methoxy group contribute the best biofilm 
activity because methoxylation is an important 
molecular feature for membrane penetration [29]. 
Compound-3 (fig. 9) had an 94.72% of biofilm 
inhibition against P.aeruginosa with concentration of 
1mg /ml as depicted in table 2. In compound 1 and 3, 
biofilm inhibitory activity was less because three 
methoxy group is present. To compare the previous 
reported data compounds with three methoxy groups 
were less active than the compounds with dimethoxy, 
because their demethoxylation was incomplete. 
 
 
Fig.7:  Percentage of biofilm inhibition in Pseudomonas aeruginosa when exposed to 
different concentrations of compound 1,2 and 3.Error bars indicate the standard deviation. 
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Fig. 8:  Percentage of biofilm inhibition in Klebsiella pneumonia when exposed to different 
Concentrations of compound 1, 2 and 3.Error bars indicate the standard deviation. 
 
 
 
Fig.9:  Percentage of biofilm inhibition in Staphylococcus epidermidis when exposed to different 
concentrations of compound 1,2 and 3.Error bars indicate the standard deviation. 
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Table 2: Biofilm inhibition (%) of three isolates with naturally isolated compounds 1,2 and 3 at different 
concentration of inhibition values are mean ± SD 
Biofilm forming 
isolates 
 
Compound 1 
 
Compound 2 
 
Compound 3 
 
P. aeruginosa   
 
 
90.375±0.1767 (1mg/ml) 
88.005±0.1909(1ug/ml) 
93.93±0.9899(1ng/ml) 
 
92.33±0.4313(1mg/ml) 
92.25±0.1414(1ug/ml) 
93.48±0.2121(1ng/ml) 
 
 
90.38±0.1414(1mg/ml) 
91.21±0.6434(1ug/ml) 
93.23±0.6363(1ng/ml) 
 
94.68±0.2404(1mg/ml) 
94.46±0.1626(1ug/ml) 
95.00±0.9192(1ng/ml) 
 
92.03±0.3040(1mg/ml) 
92.52±0.8485(1ug/ml) 
92.89±0.0141(1ng/ml) 
 
 
93.73±0.0494(1mg/ml) 
92.11±0.0212(1ug/ml) 
93.04±0.3676(1ng/ml) 
 
94.72±0.4242(1mg/ml) 
94.04±0.3676(1ug/ml) 
94.39±0.6717(1ng/ml) 
 
90.73±0.1909(1mg/ml) 
90.72±0.0565(1ug/ml) 
88.70±0.1484(1ng/ml) 
 
 
92.57±0.6293(1mg/ml) 
92.84±0.9545(1ug/ml) 
89.37±0.1060(1ng/ml) 
 
K. pneumonia 
 
 
 
 
S. epidermidis 
 
SEM image of all the three compound 
The effect of  compound 1,2 and 3 upon 
P.aeruginosa, K.pneumonia and S.epidermidis 
structural morphological changes of three different 
bacteria  were examined by SEM.SEM analysis 
revealed that in the absence of compounds exhibited 
at rod-shape,rod- shape and cocci in grape-like 
clusters with smooth surfaces(micrographs shown in 
fig.10,11 and 12).SEM of three compound treated 
with  P.aeruginosa (Fig.  10)it showed the formation 
of holes  and number of the cell was reduced at three 
different concentrations and compound 2 can inhibit 
the  adhesion of P.aeruginosa and prevent its  biofilm 
formation  at 1ng/ml. Fig.  11 Showed that , In 
treated K. pneumonia cells the number of attached 
bacterial biofilm cells was  reduced at all the three 
different concentrations of  three compound when 
compared with the control but compound 2  more 
number of cells reduced at 1ng/ml. Considering  
S.epidermidis images inhibition start at 1mg/ml of 
three compounds  and  the cell wall was ruptured and 
holes formed at 1mg/ml of  compound 3. 
  
 
 
Fig. 10:  Scanning electron micrographs of P.aeruginosa biofilm inhibition and their treatment with three 
different concentrations of (a= 1mg, b = 1ug, c= 1ng ) compound 1,2 and 3  (a) Control 
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Fig. 11: Scanning electron micrographs of  K. pneumonia biofilm inhibition and their treatment with three 
different concentrations of (a1= 1mg, b1 = 1ug, c1 = 1ng ) compound 1,2 and 3  (a1) Control 
 
 
Fig. 12: Scanning electron micrographs of  S.epidermidis biofilm inhibition and their treatment with three 
different concentrations of (a2= 1mg, b2 = 1ug, c2 = 1ng ) compound 1,2 and 3  (a2) Control 
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Microscopic evaluation of P.aeruginosa biofilms 
on catheter by SEM 
P.aeruginosa biofilm formed after 72 h incubation on 
catheter piece from each isolate was observed under 
SEM. Catheter pieces were picked up by sterile 
forceps from the SDB and gently washed in 5 ml of 
PBS to remove non adherent cells. The pieces were 
then placed in a sterilized petri plate. The biofilms 
were air dried for 3 h. The pieces were then coated 
with gold and then imaged using a SEM in a high 
vacuum mode at 8 kV as shown in fig. 13. Scanning 
electron micrographs of the biofilm were taken at 10 
kx magnification. 
 
                                            Fig. 13:  SEM image of urinary catheter 
Colonization in catheters 
Bio-Guard catheters used in this study for biofilm 
inhibition with two different nature of catheters with 
sample coated and uncoated. When compare to 
coated and uncoated catheters the  
 
uncoated shows effective results. The uncoated 
samples were treated with the compound-2 with 
ng/ml concentration as shown in fig.14 
 
 
Fig.14: P.aeruginosa biofilm growth on catheter by SEM a) control b)in the presence of compound 2 
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CONCLUSIONS: 
In this present study compound 1,2 and 3 were used 
for the first time as an antibiofilm compound. The 
results show that all the compounds have potential 
biofilm inhibition capabilities and compound 2 
inhibit the biofilm formation at very low (1ng) 
concentration level. SEM analysis revealed various 
morphological changes in all the three bacteria and 
compound 2 reduce more number of cells at 1ng. 
Compound-2 inhibits majorly in urinary catheters 
which shows good impact in medical field. This is 
the first report of my compound inhibit at low 
concentration level. 
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